Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas...

por López-Pousa, A., Martín, J., Montalar, J., de las Peñas, R., García del Muro, J., Cruz, J., Maurel, J., Escudero, P., Casado, A., Buesa, J. M., the Spanish Group for Research on Sarcomas (GEIS)
Publicado 2006

Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study

por López-Pousa, A, Losa, R, Martín, J, Maurel, J, Fra, J, Sierra, M, Casado, A, García del Muro, J, Poveda, A, Balañá, C, Martínez-Trufero, J, Esteban, E, Buesa, J M
Publicado 2006

Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A...

por Poveda, A., López-Pousa, A., Martín, J., Del Muro, J. García, Bernabé, R., Casado, A., Balañá, C., Sanmartín, O., Menéndez, M. D., Escudero, P., Cruz, J., Belyakova, Elena, Menéndez, D., Buesa, J. M.
Publicado 2005